SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
onepath
Ron
Savant
From: Brumar899/12/2024 7:40:26 AM
3 Recommendations   of 22882
 
New Covid Antibody Could Be Key To Developing Be-All and End-All Vaccine
Researchers say they discovered a new antibody that can adapt to ever-shifting variants.
President Biden coughs from Covid July 16, 2024. AP/Susan Walsh

PERRY CHIARAMONTEMonday, September 9, 202410:37:42 am


Gift this article

Researchers at the University of Texas at Austin claim they may have cracked the Covid code by discovering a new antibody that could be used to create a vaccine that could combat all variants of the virus, including those that have not emerged yet.

The UT scientists say they found the new antibody, known as SC27, in the blood sample of a single patient from the Lone Star State’s Capital, according to a report from KUT, a station under National Public Radio’s network.

Their findings, which were published in a new study, show that the SC27 can bind to spike proteins like previous antibodies, but what makes it stand out is its ability to recognize when those proteins change shape as new variants develop.

“The discovery of SC27, and other antibodies like it in the future, will help us better protect the population against current and future Covid variants,” head researcher of the study from the UT Austin’s McKetta Department of Chemical Engineering, Jason Lavinder, said in a press release by the school.
The research team believes that the new antibody can be used to create a game-changing vaccine that can protect against the ever-shifting nature of Covid and other related viruses.
“One goal of this research … is to work toward a universal vaccine that can generate antibodies and create an immune response with broad protection to a rapidly mutating virus,” said Will Voss, one of the project’s leaders, in a released statement.

In further comment to KUT, Mr. Voss said, “Due to its remarkable ability to potently neutralize even the most recent variants, SC27 could fill this void.”
The UT Austin research team, which worked in conjunction with other institutions, including the University of North Carolina, has filed for a patent for the antibody.

New Covid Antibody Could Be Key To Developing Be-All and End-All Vaccine | The New York Sun (archive.ph)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext